Drug
Atorvastatin
Atorvastatin: highest development phase Post-Market, developed by Abbott Laboratories, Dr. Reddy's, Madrigal Pharmaceuticals. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Abbott Laboratories, Dr. Reddy's, Madrigal Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Atorvastatin NCT00715273 | Post-Market | Coronary Artery Disease |
| Atorvastatin NCT02749578 | Phase 1 | Healthy |
| Atorvastatin Calcium Tablets, 80 mg NCT01645423 | Phase 1 | Healthy |
Latest
No recent events.
Follow Atorvastatin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.